Majewska, Hanna
Gorczyński, Adam
Czapiewski, Piotr
Menon, Roopika
Mueller, Judith
Lakis, Sotirios
Heuckmann, Johannes M.
Laco, Jan
Gupta, Ruta
Andreasen, Simon
Stodulski, Dominik
Iliszko, Mariola
Dziadziuszko, Rafał
Jassem, Jacek
Heukamp, Lukas C.
Biernat, Wojciech http://orcid.org/0000-0001-8462-2189
Funding for this research was provided by:
Medical University of Gdansk (02-0095/07/267, 01-0424/08/267, 02-0023/07/171)
Article History
Received: 2 August 2020
Revised: 25 October 2020
Accepted: 15 November 2020
First Online: 25 November 2020
Compliance with ethical standards
:
: Prof Rafał Dziadziuszko: Advisory board role for Pfizer, Novartis, Roche, Takeda, Merck, Seattle Genetics, and Foundation Medicine. Travel costs from Roche and AstraZeneca. Dr. Johannes Heuckmann is a full time employee of NEO New Oncology GmbH. Prof Jacek Jassem: Advisory board role for Boehringer, Astra Zeneca, BMS, and Merck. Other authors declare that they have no conflict of interest.
: The study was approved by the Independent Bioethics Committee for Scientific Research at Medical University of Gdańsk (Decision number: NKBBN/4182015)
: Not applicable.
: Not applicable.
: Not applicable.